According to the latest report by IMARC Group titled, “Intravenous (IV) solution market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the market is anticipated to reach a value of US$ 11.4 Billion by 2024, exhibiting a CAGR of 6.2% during 2019-2024.